Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Healthtrust
Covington
AstraZeneca
Boehringer Ingelheim
McKinsey
QuintilesIMS
Federal Trade Commission
Argus Health

Generated: December 17, 2018

DrugPatentWatch Database Preview

Agouron Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AGOURON PHARMS, and what generic and branded alternatives to AGOURON PHARMS drugs are available?

AGOURON PHARMS has three approved drugs.



Summary for Agouron Pharms
US Patents:0
Tradenames:1
Ingredients:1
NDAs:3

Drugs and US Patents for Agouron Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 020779-001 Mar 14, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Agouron Pharms VIRACEPT nelfinavir mesylate POWDER;ORAL 020778-001 Mar 14, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 021503-001 Apr 30, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Agouron Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 020779-001 Mar 14, 1997 5,952,343*PED ➤ Try a Free Trial
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 021503-001 Apr 30, 2003 6,162,812*PED ➤ Try a Free Trial
Agouron Pharms VIRACEPT nelfinavir mesylate POWDER;ORAL 020778-001 Mar 14, 1997 5,484,926*PED ➤ Try a Free Trial
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 021503-001 Apr 30, 2003 5,484,926*PED ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
US Army
Harvard Business School
US Department of Justice
Chinese Patent Office
Julphar
Deloitte
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.